AGAMENNONE, Mariangela
 Distribuzione geografica
Continente #
NA - Nord America 2.590
EU - Europa 2.038
AS - Asia 1.858
SA - Sud America 280
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 6.791
Nazione #
US - Stati Uniti d'America 2.515
SG - Singapore 699
CN - Cina 600
IT - Italia 450
IE - Irlanda 326
UA - Ucraina 264
SE - Svezia 251
BR - Brasile 243
TR - Turchia 211
GB - Regno Unito 208
DE - Germania 179
IN - India 164
FR - Francia 116
VN - Vietnam 103
FI - Finlandia 70
CA - Canada 53
RU - Federazione Russa 49
GR - Grecia 40
HK - Hong Kong 19
BD - Bangladesh 17
PL - Polonia 16
AR - Argentina 15
MX - Messico 13
PT - Portogallo 13
JP - Giappone 12
NL - Olanda 11
AT - Austria 10
EC - Ecuador 10
BE - Belgio 7
KR - Corea 7
CZ - Repubblica Ceca 6
ID - Indonesia 6
ZA - Sudafrica 6
EU - Europa 5
LT - Lituania 5
RO - Romania 5
ES - Italia 4
IQ - Iraq 4
AU - Australia 3
CH - Svizzera 3
DZ - Algeria 3
IR - Iran 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BH - Bahrain 2
EG - Egitto 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
MA - Marocco 2
NI - Nicaragua 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PY - Paraguay 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
BB - Barbados 1
CL - Cile 1
CO - Colombia 1
ET - Etiopia 1
GY - Guiana 1
IL - Israele 1
KN - Saint Kitts e Nevis 1
PA - Panama 1
SC - Seychelles 1
TO - Tonga 1
TV - Tuvalu 1
Totale 6.791
Città #
Singapore 474
Chandler 334
Jacksonville 333
Dublin 323
Ashburn 171
Dallas 160
Southend 144
Princeton 141
Beijing 138
Nanjing 116
Izmir 107
Chieti 104
Los Angeles 77
Cambridge 72
Santa Clara 72
Ann Arbor 65
Dearborn 65
Munich 61
Nanchang 55
The Dalles 53
Wilmington 48
New York 44
Tongling 41
Altamura 39
Woodbridge 38
Rome 32
Ho Chi Minh City 30
Buffalo 28
Redondo Beach 26
Dong Ket 25
São Paulo 24
Shenyang 23
Ottawa 21
Hebei 19
Hong Kong 19
Kunming 19
San Mateo 19
Tianjin 18
Washington 17
Jiaxing 16
Nuremberg 16
Stockholm 16
Grevenbroich 15
Boardman 14
London 14
Milan 14
Atlanta 13
Changsha 13
Montreal 13
Pune 13
Toronto 13
Denver 12
Hanoi 12
Hefei 12
Warsaw 12
Brooklyn 11
Ferrara 11
Norwalk 11
Porto 11
Andover 10
Rio de Janeiro 10
Tokyo 10
Turku 10
Jinan 9
Napoli 9
Pescara 9
Augusta 8
Manchester 8
Orem 8
Poplar 8
San Francisco 8
Siena 8
Teramo 8
Bari 7
Belo Horizonte 7
Brussels 7
Chicago 7
Curitiba 7
Leawood 7
Torino 7
Ankara 6
Biên Hòa 6
Boston 6
Brasília 6
Brno 6
Changchun 6
Haiphong 6
Hangzhou 6
Lanzhou 6
Ningbo 6
Seattle 6
Shanghai 6
Houston 5
Johannesburg 5
Lappeenranta 5
Mexico City 5
Orange 5
Seoul 5
Amsterdam 4
Chennai 4
Totale 4.139
Nome #
Peptidi della Lattoferrina per uso come inibitori ad ampio spettro dell'infezione da virus dell'influenza 254
Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids 147
Inibitori fosfonati di MMP: Influenza di variazioni strutturali in P3 sulla potenza e sulla selettività d’azione. 137
AMBER force field implementation of the boronate function to simulate the inhibition of beta-lactamases by alkyl and aryl boronic acids 134
Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2 128
Tripeptide Phosphonate Inhibitors of Matrix metalloproteinases. 128
Derivatives of m-aminophenylboronic acid as ß-lactamases inhibitors. 128
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 127
Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection 124
Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulphonamide phosphonates 122
Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus 120
alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs. 118
Sintesi enantioselettiva di inibitori fosfonati di metalloproteinasi di matrice. 118
Amber* force field implementation to dock alkyl and aryl boronic acids as ß-lactamases inhibitors. 117
Synthesis and biological evaluation of new Matrix Metalloproteinases Inhibitors. 113
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover 111
Synthesis and biological evaluation of new matrix metalloproteinases inhibitors 110
New Matrix Metalloproteinase Inhibitors Based on N-hydroxyurea as zinc-binding group: synthesis, biological evaluation and computational studies. 109
Sintesi e valutazione biologica di Acidi Aril-Solfonil-Fosfonici come Inibitori selettivi delle Metalloproteinasi di Matrice (MMP). 109
Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study 109
VIRTUAL SCREENING APPROACHES FOR THE IDENTIFICATION OF NOVEL NON-ZINC-BINDING MMPs INHIBITORS 107
An Integrated Computational Approach to Rationalize the Activity of Non-Zinc-Binding MMP-2 Inhibitors 106
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies 106
Characterization of PD-L1 binding sites by a combined FMO/GRID-DRY approach 106
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity 106
Synthesis, SAR and Biological Evaluation of alfa-Sulfonylphosphonic Acid as Selective Matrix Metalloproteinase Inhibitor 104
Amino Acid Derivatives as New Zinc Binding Groups for the Design of Selective Matrix Metalloproteinase Inhibitors 102
Synthesis and biological evaluation of sulfonyl phosphonic acids as new MMPs inhibitors. 102
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover 101
Biphenyl Sulfonylamino Methyl Bisphosphonic Acids as Inhibitors of Matrix Metalloproteinases and Bone Resorption 101
Ac‑tLeu‑Asp‑H is the minimal and highly effective human caspase‑3 inhibitor: biological and in silico studies 99
N-idrossiuree come inibitori di metalloproteinasi di matrice. 98
Bovine lactoferrin prevents influenza a virus infection by interfering with the fusogenic function of viral hemagglutinin 98
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8 94
Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors 94
Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors 91
Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening 91
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 90
AMBER force field parameterization for alkyl and aryl boronic acids. 90
Fragmenting the S100B–p53 Interaction: CombinedVirtual/Biophysical Screening Approaches to IdentifyLigands 89
Effects of Biphenyl Sulfonylamino Methyl Bisphosphonic Acids on Porphyromonas Gingivalis and Cytokine Secretion by Oral Epithelial Cells 88
Probing the S1′ Site for the Identification of Non-Zinc-Binding MMP-2 Inhibitors 88
Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors 88
Mode of binding of R- and S- sulfonamide phosphonate inhibitors in the active site of MMP-8. 87
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 86
synthesis and Activity of Endomorphin-1 and 2 analogues Incorporating Azetidine-(S)-2-carboxylic acid and Azetidine-3-carboxylic acid in place of native proline 86
Fragment-based discovery of S100B inhibitors: when structural information meets in silico prediction. 86
An Effective Virtual Screening Protocol to Identify Promising p53-MDM2 Inhibitors 85
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy 85
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 84
Multiple virtual screening approaches to identify novel, non-hydroxamic class-I HDAC inhibitors. 82
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies 80
Non-zinc-binding inhibitors of MMP-13: GRID-based approaches to rationalize the binding process 78
Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors 76
Identification of small molecules acting against H1N1 influenza A virus 74
Mimic catechins to develop selective MMP-2 inhibitors 74
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 73
Structure-based pharmacophore mapping of flexible macromolecules: targeting the S100B – p53 interaction. 72
Investigation of the N-BP Binding at FPPS by Combined Computational Approaches 72
Fragment-based discovery of S100B inhibitors combining computational and biophysical approaches. 71
Development of CDK4/6 Inhibitors: A Five Years Update 69
Matrix metalloproteinases inhibitors, synthesis and biological evaluation. 69
Antiviral Peptides as Anti-Influenza Agents 69
Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13 65
Protein-protein interactions at a glance: Protocols for the visualization of biomolecular interactions 64
Discovery of a novel tetrapeptide against influenza a virus: Rational design, synthesis, bioactivity evaluation and computational studies 61
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 58
Hampering the early aggregation of PrP-E200K protein by charge-based inhibitors: a computational study 58
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 50
Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors 49
Broad-Spectrum Activity of Small Molecules Acting against Influenza a Virus: Biological and Computational Studies 48
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? 46
Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity 44
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 43
Het(aryl)isatin to het(aryl)aminoindoline scaffold hopping: A route to selective inhibitors of matrix metalloproteinases 43
Rational Design of Novel Peptidomimetics against Influenza A Virus: Biological and Computational Studies 40
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 39
Inhibition of Pseudomonas aeruginosa Carbonic Anhydrases, Exploring Ciprofloxacin Functionalization Toward New Antibacterial Agents: An In-Depth Multidisciplinary Study 35
Inhibition of Human Coronavirus 229E by Lactoferrin-Derived Peptidomimetics 30
Design and Evaluation of Synthesized Pyrrole Derivatives as Dual COX-1 and COX-2 Inhibitors Using FB-QSAR Approach 12
Totale 7.145
Categoria #
all - tutte 29.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021254 0 0 0 0 0 71 14 9 21 57 43 39
2021/2022354 7 7 12 85 27 4 4 21 26 11 46 104
2022/20231.003 98 122 72 91 94 212 59 80 106 13 31 25
2023/2024530 32 20 36 6 28 202 112 7 6 36 6 39
2024/20251.199 56 239 164 10 15 47 25 110 111 68 145 209
2025/20261.326 218 126 331 392 240 19 0 0 0 0 0 0
Totale 7.145